Status:
COMPLETED
Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy
Lead Sponsor:
State University of New York - Downstate Medical Center
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Conditions:
HIV/AIDS
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This study assesses the feasibility and acceptability of the APPEAL program, a 3-session intervention designed to promote positive affect among men and women living with HIV infection. Forty participa...
Detailed Description
There is strong reason to expand the scope of current adherence programs to include consideration of a group of health protective variables known as 'psychosocial assets'. These assets include cogniti...
Eligibility Criteria
Inclusion
- Receiving HIV care at site of recruitment
- Prescribed an HIV antiretroviral regimen
- HIV RNA viral load less than 200 copies/mL in last six months
Exclusion
- Unable to communicate in English
- Prior participation in formative components of the study
- Plans to move outside of New York City in next six months
- Has cognitive impairment that would limit ability to provide informed consent
Key Trial Info
Start Date :
October 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 26 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04035759
Start Date
October 16 2019
End Date
April 26 2021
Last Update
November 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SUNY Downstate Health Sciences University
Brooklyn, New York, United States, 11231